Triazolopyrimidine compounds and uses thereof
US11931363B2 · kind B2 · utility
0Cited by
7References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 2021 |
| Grant date | Mar 19, 2024 |
| Priority date | — |
| Expiry date | May 27, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.